insider24.ch
Holding / family officeRegistered location :4056 BaselGroup :Novartis AG

Novartis Stiftung für KaderausbildungDeclared Swiss shareholdings

Novartis Stiftung für Kaderausbildung: 0 Swiss companies with a declared holding.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
—
Swiss companies held
0
Largest position
—
12-month trend
Not determinable
0 rate rises · 0 rate falls
Latest filing
…

Declared Swiss portfolio

Latest declared rate per company

No active declared position.

How to read these figures?

Rates come from the 18 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure2 controlled by

Controlled by

Group entities that file jointly with this shareholder as its head.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 0

90 days · Downward crossings

0

visible history: 0

First disclosure: —Last disclosure: —

Latest shareholding disclosures

PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

7.036%Voting rights acquired25.03.2025
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10.005%Voting rights acquired22.02.2025
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

9.986%Voting rights acquired21.02.2025
Show 15 older disclosures
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10%Voting rights acquired20.02.2025
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

9.999%Voting rights acquired31.01.2025
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

9.893%Voting rights acquired31.01.2025
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10%Voting rights acquired30.01.2025
Below thresholdShareholdings

Sandoz Group AG

Novartis Stiftung für Kaderausbildung · Single shareholder

3%Below threshold23.05.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

6.625%Voting rights acquired19.03.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10.001%Voting rights acquired19.02.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

9.979%Voting rights acquired15.02.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10%Voting rights acquired07.02.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

9.978%Voting rights acquired02.02.2024
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

10.004%Voting rights acquired01.12.2023
PurchaseShareholdings

Sandoz Group AG

Novartis Stiftung für Kaderausbildung · Single shareholder

4.298%Voting rights acquired06.10.2023
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

7.573%Voting rights acquired21.03.2023
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

11.733%Voting rights acquired06.01.2023
PurchaseShareholdings

Novartis AG

Novartis Stiftung für Kaderausbildung · Single shareholder

11.733%Voting rights acquired06.01.2023

insider24.ch

Follow Novartis Stiftung für Kaderausbildung’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Common questions

Which Swiss companies are in Novartis Stiftung für Kaderausbildung’s disclosed portfolio?

No active holding identified in available disclosures.

What is Novartis Stiftung für Kaderausbildung’s latest disclosure?

The latest available disclosure was published on 25.03.2025 and concerns Novartis AG. Threshold disclosures do not describe every purchase or sale.

Explore further

Recent insider purchases

What are insiders doing at companies disclosed by this shareholder?

All purchases this week

Insider barometer

Compare insider purchases and sales across the Swiss stock exchange over 30 days.

View the Swiss barometer

These signals are not investment advice.